This library lists the primary references used across the site’s rewritten ciprofloxacin safety pages. Article-level source lists show which references support each topic.
Last reviewed: August 8, 2026
Core drug information
MedlinePlus provides patient-oriented instructions and warning symptoms. DailyMed provides current product labeling, boxed warnings, interactions, and use-in-specific-population sections.
FDA safety communications
FDA communications explain major class-label changes involving disabling effects, serious blood-glucose and mental-health reactions, and aortic aneurysm/dissection risk. They supplement rather than replace the current product label.
Topic-specific government sources
CDC material is used for C. difficile education. LactMed is used when breastfeeding exposure is discussed. These sources are linked directly so readers can verify context.
How claims are handled
A source link is not decoration. Each retained article identifies the formulation and patient group, avoids claiming a precise risk rate when the source does not provide one, and distinguishes label instructions from general editorial advice.